Aim for remission or "personal best" using combination DMARD therapy with methotrexate and hydroxychloroquine

Wm. Bensen, W. Bensen

ABSTRACT
Combination disease-modifying antirheumatic drug therapy with methotrexate and hydroxychloroquine has changed the course of rheumatoid arthritis. Better management requires "front of the line" care, effective drug combinations, and a goal of "Personal Best." The Pincus phenomenon - the discrepancy between subjective satisfaction and objective progression - may be minimized in clinical practice by questionnaires and Snapshot™.

Key words
Combination DMARDs, methotrexate, plaquenil, "Personal Best", Snapshot™, Pincus phenomenon.

William G. Bensen, BSc, MD, FRCP (C), St. Joseph’s Hospital/McMaster University, Hamilton, Ontario, Canada; Wynn Bensen, BA.

Please address correspondence and reprint requests to: William G. Bensen, MD, 25 Charlton Avenue, Suite 203, Hamilton, Ontario L8N 1Y2, Canada.

Clin Exp Rheumatol 1999; 17 (Suppl. 18): S95 - S101.
© Copyright Clinical and Experimental Rheumatology 1999.